Bank of New York Mellon Corp Trims Holdings in Amedisys, Inc. (NASDAQ:AMED)

Bank of New York Mellon Corp trimmed its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 19.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 239,989 shares of the health services provider's stock after selling 58,881 shares during the period. Bank of New York Mellon Corp owned 0.73% of Amedisys worth $22,230,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. MassMutual Private Wealth & Trust FSB increased its stake in shares of Amedisys by 56.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after buying an additional 120 shares during the period. Fifth Third Bancorp increased its position in Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 141 shares during the period. UMB Bank n.a. boosted its holdings in shares of Amedisys by 100.0% during the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after buying an additional 193 shares in the last quarter. Johnson Financial Group Inc. bought a new position in shares of Amedisys during the 4th quarter worth approximately $55,000. Finally, Covestor Ltd boosted its holdings in shares of Amedisys by 48.8% during the 4th quarter. Covestor Ltd now owns 1,037 shares of the health services provider's stock worth $94,000 after buying an additional 340 shares in the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Performance

Shares of NASDAQ:AMED traded down $0.01 during mid-day trading on Friday, reaching $97.46. 237,080 shares of the company traded hands, compared to its average volume of 413,194. The company's 50 day moving average price is $96.01 and its 200-day moving average price is $93.73. The firm has a market cap of $3.20 billion, a PE ratio of 35.96, a PEG ratio of 1.32 and a beta of 0.94. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.29 and a quick ratio of 1.29. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. The company had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a return on equity of 12.52% and a net margin of 3.79%. The firm's revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.03 EPS. On average, equities analysts expect that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Wall Street Zen lowered Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Royal Bank Of Canada reissued an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Amedisys currently has a consensus rating of "Hold" and a consensus target price of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.